Related Experiment Video
Updated: Jun 4, 2026

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
Atopic dermatitis Yardstick: A new era of topical and systemic treatments
Anna De Benedetto1, Mark Boguniewicz2, Luz Fonacier3
1Department of Dermatology, University of Rochester Medical Center, Rochester, New York.
Abstract:
The atopic dermatitis (AD) Yardstick articles aim to provide an up-to-date review of AD therapy for clinicians. The first 2 AD Yardstick articles were published in 2018 and 2023. Since the last update, multiple medications have been added to the armamentarium of AD. These include roflumilast cream, tapinarof cream, lebrikizumab, and nemolizumab. In the current AD Yardstick article, we aim to provide evidence-based information on these new treatments and updated information on previously reviewed therapies. A new feature of the AD Yardstick article is the addition of patient vignettes, which provide a practical guide and clinical pearls for clinicians.
Related Concept Videos
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Acne Infection
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma III: Clinical Manifestations
